| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Apr―10 |
The International Pharmacopoeia: Focus, Processes, Response to COVID-19 and Collaboration with other Pharmacopoeias |
H. Schmidt, J. Sawyer, K. Zribi, R. Van der Werf |
| 2 |
[GO] |
2021―Mar―10 |
Planning Bioequivalence Studies in the Context of the COVID-19 Pandemic |
D. P. Romodanovsky, A. L. Khokhlov, D. V. Goryachev |
| 3 |
[GO] |
2020―Sep―18 |
Safety of Hydroxychloroquine, Favipiravir, and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19 |
B. K. Romanov |
|
